# New Enterprise Associates' Biotech Investments: 104 Startups in Its Portfolio (2026) > The 104 Biotech startups New Enterprise Associates has backed, by stage: $16B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/new-enterprise-associates-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series C and later 31 - [*BH* Bright Health](https://millionrounds.com/company/bright-health) - [23andMe](https://millionrounds.com/company/23andme) - [Trevi Therapeutics](https://millionrounds.com/company/trevi-therapeutics) - [CVRx](https://millionrounds.com/company/cvrx) - [SetPoint Medical](https://millionrounds.com/company/setpoint-medical) - [Welltok](https://millionrounds.com/company/welltok) - [Metacrine](https://millionrounds.com/company/metacrine) - [*D* Dermira](https://millionrounds.com/company/dermira) - [Mersana Therapeutics](https://millionrounds.com/company/mersana-therapeutics) - [*3B* 3-V Biosciences](https://millionrounds.com/company/3-v-biosciences) - [Moximed](https://millionrounds.com/company/moximed) - [Escient Pharmaceuticals](https://millionrounds.com/company/escient-pharmaceuticals) - [VytronUS](https://millionrounds.com/company/vytronus) - [Ivantis](https://millionrounds.com/company/ivantis) - [*N* NightstaRx](https://millionrounds.com/company/nightstarx) - [Hydra Biosciences](https://millionrounds.com/company/hydra-biosciences) - [Complexa](https://millionrounds.com/company/complexa) - [*A* Amplyx](https://millionrounds.com/company/amplyx) - [Metavention](https://millionrounds.com/company/metavention) - [MBX Biosciences](https://millionrounds.com/company/mbx-biosciences) - [CareZone](https://millionrounds.com/company/carezone) - [*G* GOQii](https://millionrounds.com/company/goqii) - [Predictive Biosciences](https://millionrounds.com/company/predictive-biosciences) - [Allay Therapeutics](https://millionrounds.com/company/allay-therapeutics) +7 more ## Stage not reported 25 - [Mirum Pharmaceuticals](https://millionrounds.com/company/mirum-pharmaceuticals) - [Phathom Pharmaceuticals](https://millionrounds.com/company/phathom-pharmaceuticals) - [Epizyme](https://millionrounds.com/company/epizyme) - [Monte Rosa Therapeutics](https://millionrounds.com/company/monte-rosa-therapeutics) - [Pionyr Immunotherapeutics](https://millionrounds.com/company/pionyr-immunotherapeutics) - [EarLens](https://millionrounds.com/company/earlens) - [Nkarta Therapeutics](https://millionrounds.com/company/nkarta-therapeutics) - [X4 Pharmaceuticals](https://millionrounds.com/company/x4-pharmaceuticals) - [Intrinsic Therapeutics](https://millionrounds.com/company/intrinsic-therapeutics) - [*N* Neotract](https://millionrounds.com/company/neotract) - [NeuroPace](https://millionrounds.com/company/neuropace) - [Acrivon Therapeutics](https://millionrounds.com/company/acrivon-therapeutics) - [Amber Therapeutics](https://millionrounds.com/company/amber-therapeutics) - [AviadoBio](https://millionrounds.com/company/aviadobio) - [Korro Bio](https://millionrounds.com/company/korro-bio) - [Aetion](https://millionrounds.com/company/aetion) - [*C* Cydan](https://millionrounds.com/company/cydan) - [Inozyme](https://millionrounds.com/company/inozyme) - [ChromaCode](https://millionrounds.com/company/chromacode) - [Centrexion Therapeutics](https://millionrounds.com/company/centrexion-therapeutics) - [Vesper Medical](https://millionrounds.com/company/vesper-medical) - [Tarveda Therapeutics](https://millionrounds.com/company/tarveda-therapeutics) - [Launchpad Therapeutics](https://millionrounds.com/company/launchpad-therapeutics) - [Tempest Therapeutics](https://millionrounds.com/company/tempest-therapeutics) +1 more ## Series B 22 - [Gossamer Bio](https://millionrounds.com/company/gossamer-bio) - [Arcellx](https://millionrounds.com/company/arcellx) - [Cardurion Pharmaceuticals](https://millionrounds.com/company/cardurion-pharmaceuticals) - [Shape Therapeutics](https://millionrounds.com/company/shape-therapeutics) - [Galera Therapeutics](https://millionrounds.com/company/galera-therapeutics) - [Annexon Biosciences](https://millionrounds.com/company/annexon-biosciences) - [Tune Therapeutics](https://millionrounds.com/company/tune-therapeutics) - [FIRE1](https://millionrounds.com/company/fire1) - [Senti Biosciences](https://millionrounds.com/company/senti-biosciences) - [Black Diamond Therapeutics](https://millionrounds.com/company/black-diamond-therapeutics) - [*OP* Oyster Point](https://millionrounds.com/company/oyster-point) - [MORE Health](https://millionrounds.com/company/more-health) - [*I* Imara](https://millionrounds.com/company/imara) - [Akouos](https://millionrounds.com/company/akouos) - [*IV* Intact Vascular](https://millionrounds.com/company/intact-vascular) - [Therachon](https://millionrounds.com/company/therachon) - [Ra Pharmaceuticals](https://millionrounds.com/company/ra-pharmaceuticals) - [Lumena Pharmaceuticals](https://millionrounds.com/company/lumena-pharmaceuticals) - [Avenzo Therapeutics](https://millionrounds.com/company/avenzo-therapeutics) - [Rotation Medical](https://millionrounds.com/company/rotation-medical) - [858 Therapeutics](https://millionrounds.com/company/858-therapeutics) - [*N* Nucleonics](https://millionrounds.com/company/nucleonics) ## Series A 22 - [Celcuity](https://millionrounds.com/company/celcuity) - [Rhythm Pharmaceuticals](https://millionrounds.com/company/rhythm-pharmaceuticals) - [Ouro Medicines](https://millionrounds.com/company/ouro-medicines) - [Nexo Therapeutics](https://millionrounds.com/company/nexo-therapeutics) - [*IP* Inozyme Pharma](https://millionrounds.com/company/inozyme-pharma) - [*RP* Reneo Pharmaceuticals](https://millionrounds.com/company/reneo-pharmaceuticals) - [Satsuma Pharmaceuticals](https://millionrounds.com/company/satsuma-pharmaceuticals) - [Code Biotherapeutics](https://millionrounds.com/company/code-biotherapeutics) - [Tagworks Pharmaceuticals](https://millionrounds.com/company/tagworks-pharmaceuticals) - [Synlogic](https://millionrounds.com/company/synlogic) - [Tectora Therapeutics](https://millionrounds.com/company/tectora-therapeutics) - [Slope](https://millionrounds.com/company/slope) - [Envisia Therapeutics](https://millionrounds.com/company/envisia-therapeutics) - [*V* Vtesse](https://millionrounds.com/company/vtesse) - [*OM* Orpho Med](https://millionrounds.com/company/orpho-med) - [POLYNEURON](https://millionrounds.com/company/polyneuron) - [*Q* Qpex](https://millionrounds.com/company/qpex) - [*TT* Tiburio Therapeutics](https://millionrounds.com/company/tiburio-therapeutics) - [Sorriso Pharmaceuticals](https://millionrounds.com/company/sorriso-pharmaceuticals) - [*X* Xoc](https://millionrounds.com/company/xoc) - [Lumos Pharma](https://millionrounds.com/company/lumos-pharma) - [*DH* Docent Health](https://millionrounds.com/company/docent-health) ## Growth 2 - [Intarcia Therapeutics](https://millionrounds.com/company/intarcia-therapeutics) - [American Pathology Partners](https://millionrounds.com/company/american-pathology-partners) ## Pre-seed and seed 2 - [*R* Rhythm](https://millionrounds.com/company/rhythm) - [Curisium](https://millionrounds.com/company/curisium) ## Segment by segment ### Series C and later 31 startups · $5.2B raised - [*BH* **Bright Health**](https://millionrounds.com/company/bright-health) United States $1.1B - [**23andMe**](https://millionrounds.com/company/23andme) United States $729M - [**Trevi Therapeutics**](https://millionrounds.com/company/trevi-therapeutics) Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus. United States $386M - [**CVRx**](https://millionrounds.com/company/cvrx) CVRx is a medical device company developing implantable technology for the treatment of high blood pressure. United States $369M - [**SetPoint Medical**](https://millionrounds.com/company/setpoint-medical) SetPoint Medical is a commercial-stage medical technology company founded in 2007, focused on developing bioelectronic therapies f United States $256M - [**Welltok**](https://millionrounds.com/company/welltok) Silverlink Communications is a healthcare IT company that develops solutions for patient communications and engagement. United States $239M - [**Metacrine**](https://millionrounds.com/company/metacrine) Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs. United States $173M - [*D* **Dermira**](https://millionrounds.com/company/dermira) Dermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology. United States $169M ### Stage not reported 25 startups · $4.0B raised - [**Mirum Pharmaceuticals**](https://millionrounds.com/company/mirum-pharmaceuticals) Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies. United States $669M - [**Phathom Pharmaceuticals**](https://millionrounds.com/company/phathom-pharmaceuticals) Phathom Pharmaceuticals is a biopharmaceutical company. United States $530M - [**Epizyme**](https://millionrounds.com/company/epizyme) Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors. United States $332M - [**Monte Rosa Therapeutics**](https://millionrounds.com/company/monte-rosa-therapeutics) Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways. Switzerland $300M - [**Pionyr Immunotherapeutics**](https://millionrounds.com/company/pionyr-immunotherapeutics) Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment. - $275M - [**EarLens**](https://millionrounds.com/company/earlens) Earlens is a medical technology company transforming the hearing experience with the only direct sound delivery system. United States $248M - [**Nkarta Therapeutics**](https://millionrounds.com/company/nkarta-therapeutics) Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies. United States $240M - [**X4 Pharmaceuticals**](https://millionrounds.com/company/x4-pharmaceuticals) X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment. United States $193M ### Series B 22 startups · $3.5B raised - [**Gossamer Bio**](https://millionrounds.com/company/gossamer-bio) Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products. United States $567M - [**Arcellx**](https://millionrounds.com/company/arcellx) Arcellx is a clinical-stage biotechnology company focused on developing innovative immunotherapies for cancer and other incurable diseases. United States $285M - [**Cardurion Pharmaceuticals**](https://millionrounds.com/company/cardurion-pharmaceuticals) Cardurion Pharmaceuticals is a clinical-stage biotechnology company founded in 2017, focused on developing innovative therapeutics United States $260M - [**Shape Therapeutics**](https://millionrounds.com/company/shape-therapeutics) A biotechnology company developing RNA technologies to shape the future of gene therapy United States $260M - [**Galera Therapeutics**](https://millionrounds.com/company/galera-therapeutics) Galera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer. United States $219M - [**Annexon Biosciences**](https://millionrounds.com/company/annexon-biosciences) Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders. United States $180M - [**Tune Therapeutics**](https://millionrounds.com/company/tune-therapeutics) Tune Therapeutics is a biotechnology company based in Durham, North Carolina, founded in 2020. United States $175M - [**FIRE1**](https://millionrounds.com/company/fire1) FIRE1, officially known as The Foundry Innovation and Research 1, Ltd., is a connected medical device company based in Dublin, Ireland. Ireland $170M ### Series A 22 startups · $2.5B raised - [**Celcuity**](https://millionrounds.com/company/celcuity) Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients. United States $1.0B - [**Rhythm Pharmaceuticals**](https://millionrounds.com/company/rhythm-pharmaceuticals) Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics United States $311M - [**Ouro Medicines**](https://millionrounds.com/company/ouro-medicines) Ouro Medicines is a biotechnology company based in South San Francisco, established in 2025 by Monograph Capital in partnership with GSK. United States $120M - [**Nexo Therapeutics**](https://millionrounds.com/company/nexo-therapeutics) Nexo Therapeutics is a biotechnology company dedicated to discovering and developing small-molecule therapies, particularly in onc United States $120M - [*IP* **Inozyme Pharma**](https://millionrounds.com/company/inozyme-pharma) United States $116M - [*RP* **Reneo Pharmaceuticals**](https://millionrounds.com/company/reneo-pharmaceuticals) Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases. United States $105M - [**Satsuma Pharmaceuticals**](https://millionrounds.com/company/satsuma-pharmaceuticals) Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product. United States $92M - [**Code Biotherapeutics**](https://millionrounds.com/company/code-biotherapeutics) Code Biotherapeutics (Code Bio) is a biotechnology company founded in 2020, based in Hatfield, Pennsylvania. United States $75M ### Growth 2 startups · $1.1B raised - [**Intarcia Therapeutics**](https://millionrounds.com/company/intarcia-therapeutics) Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment. United States $1.1B - [**American Pathology Partners**](https://millionrounds.com/company/american-pathology-partners) AP2 is a provider of anatomic pathology and related specialized testing services. United States $6.0M ### Pre-seed and seed 2 startups · $46M raised - [*R* **Rhythm**](https://millionrounds.com/company/rhythm) United States $42M - [**Curisium**](https://millionrounds.com/company/curisium) Innovative Healthcare Contracting United States $3.5M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names New Enterprise Associates as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **New Enterprise Associates' AI portfolio** 108 startups · $50B](https://millionrounds.com/portfolio-maps/new-enterprise-associates-ai-portfolio)[Sector portfolio **New Enterprise Associates' Big Data & Analytics portfolio** 39 startups · $2.6B](https://millionrounds.com/portfolio-maps/new-enterprise-associates-big-data-analytics-portfolio)[Sector portfolio **New Enterprise Associates' Fintech portfolio** 38 startups · $8.9B](https://millionrounds.com/portfolio-maps/new-enterprise-associates-fintech-portfolio)[Sector portfolio **New Enterprise Associates' IT Services portfolio** 38 startups · $4.3B](https://millionrounds.com/portfolio-maps/new-enterprise-associates-it-services-portfolio)[Sector portfolio **New Enterprise Associates' Internet portfolio** 32 startups · $4.1B](https://millionrounds.com/portfolio-maps/new-enterprise-associates-internet-portfolio)[Sector portfolio **New Enterprise Associates' Software portfolio** 29 startups · $1.1B](https://millionrounds.com/portfolio-maps/new-enterprise-associates-software-portfolio) ## Raising from investors like New Enterprise Associates? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)